CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in Bioprocess and Biotechnology Engineering from the Federal University of Tocantins (UFT) in 2016. During her undergraduate studies, she completed internships at the Chemistry and Biomolecules Vaccines Laboratories (LABVAC) at UFT, the Skin Biology Group of the Department of Clinical and Toxicological Analysis at FCF-USP in São Paulo (2016), and the Pharmacotechnology and Pharmaceutical Technology Laboratory at FCFAr-UNESP (2017). Masters degree in Biosciences and Biotechnology Applied to Pharmacy (2019) from UNESP, supported by a CAPES scholarship (08/2017 to 04/2018, code 001) and funded by FAPESP (Process 2017/25190-8). During the program, she was a visiting student at Trinity College Dublin (FAPESP Process No. 2018/26422-2, 2019), focusing on the functionalization of drug nanocarriers for prostate cancer treatment. PhD in Sciences (2025) from the Faculty of Pharmaceutical Sciences at UNESP, funded by FAPESP (Process 2020/09396-8). During the doctorate, she was a visiting PhD student at the University of Sheffield (FAPESP Process No. 2023/10385-9, 20232024), specializing in nanomaterials and tissue engineering. The research explored the application of photodynamic therapy combined with nanotechnology for targeted drug delivery in cancer treatment. Currently conducting postdoctoral research at UNESP, funded by FAPESP (Process No. 2025/03631-9), focusing on the development of a skin cancer-on-a-chip model to test antitumor compounds incorporated into biomaterials for topical application. The project integrates microfluidics, biomaterials, and tissue engineering with the goal of creating a more physiologically relevant preclinical platform while reducing the reliance on animal models. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Skin cancer is one of the most prevalent neoplasms worldwide, necessitating the development of innovative therapeutic approaches. Conventional biological models, such as monolayer cell cultures and animal testing, have significant limitations in replicating the complexity of the tumor microenvironment. In this context, "organ-on-a-chip" technology emerges as a promising alternative, enabl…
The tumor environment is highly complex which makes the development of new therapeutic approaches challenging. However, the vast majority of in vitro study models are based on cell culture in two dimensions (2D) since the investigation in these models are simple and can be easily reproduced. However, these systems have limitations such as false positive responses. Therefore, in order to c…
Prostate cancer is the most common urological malignancy and the second leading cause of cancer mortality in the world. Treatment is initiated through surgical interventions covering radical prostatectomy, followed by active surveillance, radiotherapy, as well as therapies involving androgen deprivation and immunotherapies. Chemotherapy is also widely used and recent studies have demonstr…
The tumor microenvironment is highly complex, which makes the development of new therapeutic approaches challenging. For the development and study using three-dimensional models (spheroids, organoids and tissue-engineered constructions based on extracellular matrix scaffolds) it is important to understand the methods available for generating them and their response to drugs/photosensitize…
Prostate cancer (PC) is the most common malignant urologic neoplasm and the second leading cause of cancer mortality in the world. Treatment is initiated through surgical interventions covering radical prostatectomy, followed by active surveillance, radiotherapy, as well as therapies involving androgen deprivation and immunotherapies. Chemotherapy is also widely used and recent studies ha…
| 1 / 1 | Ongoing scholarships in Brazil |
| 2 / 2 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 5 / 5 | All Scholarships |
| Associated processes | |